![]() |
市场调查报告书
商品编码
1836232
生物银行冷藏设备市场-全球和区域分析:按服务细分、最终用户和区域进行分析和预测(2024-2033 年)Biobanking Cold Storage Equipment Market - A Global and Regional Analysis: Focus on Offering, End User, and Region - Analysis and Forecast, 2024-2033 |
||||||
全球生物银行冷藏设备市场预计将从 2023 年的 14.106 亿美元强劲成长。
预计到 2033 年将达到 28.899 亿美元,2024 年至 2033 年的复合年增长率为 7.55%。
这一市场的强劲成长是由对人体组织、血液和 DNA 等生物样本长期储存日益增长的需求所驱动的。这些样本在基因组学、製药和生物技术等研究领域中发挥着至关重要的作用,推动了对先进冷藏解决方案的需求。市场细分为设备、配件和耗材、软体和服务。其中,设备部分占据主导地位,冷冻库、超冷藏系统和冰箱成为生物库的重要组成部分。温度控制系统的技术创新和对个人化医疗日益增长的兴趣进一步推动了对高品质和可靠冷藏设备的需求。此外,对生物库更严格的监管要求预计将推动对坚固安全的储存设施的需求。此外,对精准医疗研发的投资增加也在推动市场成长。
| 主要市场统计数据 | |
|---|---|
| 预测期 | 2024-2033 |
| 2024年评估 | 15.9亿美元 |
| 2033年预测 | 28.899亿美元 |
| 复合年增长率 | 7.55% |
区域细分
欧洲
欧洲仍然是全球生物银行冷藏设备市场的领先地区。凭藉其强大的医疗基础设施、对研发的高度重视以及政府对生命科学领域的支持,该地区拥有世界上数量最多的生物样本库。英国、德国、法国和荷兰等国家是主要贡献者,在精准医疗、基因组学和生物医学研究方面投入了大量资金。此外,欧洲严格的生物样本库法规环境必将增加对高品质冷藏解决方案的需求,从而进一步推动市场成长。大量主要企业和研究机构的存在也巩固了欧洲在市场上的主导地位。
北美洲
北美,尤其是美国,在全球市场占有重要份额。该地区凭藉先进的技术力、强大的製药业以及对生命科学研究的大量投资,正在推动市场扩张。个人化医疗的日益增长以及主要医疗和学术研究机构的活动,正在推动对可靠低温储存设备的需求。鼓励建立生物样本库的政府优惠政策也促进了市场成长。
亚太地区
亚太地区是成长最快的地区。生物技术和製药行业的快速发展,以及不断增加的研究投入,推动了中国、日本、印度和韩国等国家生物样本库的发展。这些国家正在建造生物样本库基础设施,以满足日益增长的基因组学研究、诊断和精准医疗需求。医疗成本的上涨和临床试验的增加也刺激了对先进冷藏解决方案的需求。随着该地区持续投资于生物银行建设,对高效、扩充性冷藏设备的需求预计将进一步成长。
中东和非洲
中东和非洲地区是一个发展中市场。儘管目前的市占率相对较小,但阿联酋和沙乌地阿拉伯等国家正在大力投资生物技术和基因组学,并建造生物样本库基础设施。研究合作的增加以及人们对生物样本库在医学研究中重要性的认识不断提高,正在推动该地区对冷藏解决方案的需求。
拉丁美洲
拉丁美洲生物银行冷藏设备市场正稳定成长,其中巴西、墨西哥和阿根廷等国家领先。政府支持和不断扩张的生物技术产业正在推动市场扩张。然而,一些国家的经济挑战和研发投入不足限制了其成长。儘管如此,随着医疗和科研基础设施的改善,冷藏解决方案的需求预计将持续成长。
本报告研究了全球生物银行冷藏设备市场,并总结了主要趋势、市场影响因素分析、法律规范、市场规模趋势和预测、各个细分市场和主要国家的详细分析、竞争格局以及主要企业的概况。
This report can be delivered within 1 working day.
Introduction of Biobanking Cold Storage Equipment Market
The global biobanking cold storage equipment market, valued at $1,410.6 million in 2023, is on a robust growth trajectory and is anticipated to reach $2,889.9 million by 2033. This market is expected to expand at a compound annual growth rate (CAGR) of 7.55% between 2024 and 2033. The global biobanking cold storage equipment market is experiencing robust growth due to the increasing demand for the long-term preservation of biological samples, such as human tissues, blood, and DNA. These samples are pivotal in research areas such as genomics, pharmaceuticals, and biotechnology, fueling the need for advanced cold storage solutions. The market is segmented by offerings, including equipment, accessories and consumables, software, and services. Among these, the equipment segment dominates, with freezers, cryogenic storage systems, and refrigerators being essential components in biobanks. Technological advancements in temperature control systems, along with the growing trend towards personalized medicine, have heightened the need for high-quality and reliable cold storage solutions. Furthermore, as regulatory requirements for biobanks become more stringent, the demand for robust and secure cold storage equipment is expected to rise. The increasing investment in research and development of precision medicine further contributes to the market's expansion.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2024 - 2033 |
| 2024 Evaluation | $1,500.9 Million |
| 2033 Forecast | $2,889.9 Million |
| CAGR | 7.55% |
Regional Segmentation:
Europe
Europe remains the leading region in the global biobanking cold storage equipment market. The region is home to the highest number of biobanks, driven by a robust healthcare infrastructure, a strong focus on research and development, and government support for life sciences initiatives. Countries like the U.K, Germany, France, and the Netherlands are key contributors, with substantial investments in precision medicine, genomics, and biomedical research. Additionally, Europe's strict regulatory environment for biobanks ensures the demand for high-quality cold storage solutions, further boosting market growth. The presence of major players and research institutions also strengthens Europe's dominant position in the market.
North America
North America, particularly the U.S., holds a significant share of the global biobanking cold storage equipment market. The region benefits from advanced technological capabilities, a strong pharmaceutical industry, and substantial investments in life sciences research. The growing trend toward personalized medicine, alongside major healthcare organizations and academic research institutions, drives demand for reliable cold storage equipment. The region also benefits from favorable government policies that encourage the establishment of biobanks, thus contributing to market growth.
Asia-Pacific
The Asia-Pacific region is the fastest-growing market for biobanking cold storage equipment. Rapid advancements in biotechnology and pharmaceuticals, coupled with increasing research investments, drive the growth of biobanks in countries like China, Japan, India, and South Korea. These countries are expanding their biobanking infrastructure to support the growing demand for genomics research, diagnostics, and precision medicine. The rise in healthcare expenditures and the increasing number of clinical trials in the region also stimulate demand for advanced cold storage solutions. As the region continues to invest in biobanking capabilities, the demand for efficient and scalable cold storage equipment will continue to rise.
Middle East & Africa
The Middle East and Africa (MEA) region is a developing market for biobanking cold storage equipment. While currently holding a smaller market share, countries like the UAE and Saudi Arabia are advancing their biobanking infrastructure, supported by growing investments in biotechnology and genomics. Increasing research collaborations and awareness about the importance of biobanks in medical research are driving demand for cold storage solutions in the region.
Latin America
Latin America is experiencing steady growth in the biobanking cold storage equipment market, particularly in countries like Brazil, Mexico, and Argentina. Government initiatives and a growing biotechnology sector are contributing to market expansion. However, economic challenges and lower research investments in some countries limit growth, though demand for cold storage solutions is expected to rise as the region develops its healthcare and research infrastructure.
Recent Developments in the Global Biobanking Cold Storage Equipment Market
How can this report add value to an organization?
Product/Innovation Strategy: This report provides valuable insights into the latest advancements in biobanking cold storage equipment, including innovations in temperature control, automation, and cloud-based monitoring systems. Organizations can use these insights to identify opportunities for product differentiation, develop next-generation cold storage solutions, and integrate cutting-edge technologies to meet the growing demands of biobanks and personalized medicine.
Growth/Marketing Strategy: The report offers detailed regional and market segment insights, enabling organizations to target high-growth markets such as Asia-Pacific, where demand for biobanking infrastructure is rapidly expanding. By understanding market trends and regional dynamics, companies can align their marketing strategies to effectively position their products in fast-growing regions like North America and Europe, capitalizing on the increasing need for advanced cold storage solutions.
Competitive Strategy: By analyzing market share, key players, and industry trends, this report allows organizations to evaluate competitive dynamics, identify market leaders, and develop strategies to gain a competitive edge. This can include forming strategic partnerships, entering new markets, and developing innovative product offerings to meet the evolving needs of biobanks and research institutions.
Methodology
Key Considerations and Assumptions in Market Engineering and Validation
Primary Research:
The primary sources involve industry experts in biobanking cold storage equipment, including the market players offering biobanking cold storage equipment. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:
Secondary Research
Open Sources
The key data points taken from the secondary sources include:
Key Market Players and Competition Synopsis
The competitive landscape of the global biobanking cold storage equipment market is dominated by several key players, each offering cutting-edge technologies to meet the growing demand for reliable cold storage solutions. Leading companies such as Thermo Fisher Scientific, Inc., Azenta, Inc., and PHC Holding Corporation are at the forefront, providing a wide range of equipment including freezers, cryogenic storage systems, and refrigerators that cater to diverse biobanking needs. Other prominent players like Haier Biomedical, Eppendorf SE, and Trane Technologies plc offer specialized cold storage systems designed to meet the rigorous demands of biobanks. The market is highly competitive, with these players continually advancing their product portfolios by integrating digital technologies like cloud-based monitoring and automation. Companies such as MGI Tech Co., Ltd, Arctiko, Labcold, Esco Micro Pte. Ltd, Avantor, Inc., BioLife Solutions, Inc., Hamilton Company, and IC Biomedical, LLC also contribute to the market through innovation and strategic partnerships, positioning themselves as strong contenders in this growing industry.
Some prominent names established in the global biobanking cold storage equipment market are:
Scope and Definition